Literature DB >> 8974623

Update on the pathophysiology and pathology of acute spinal cord injury.

C H Tator1.   

Abstract

There is evidence from both clinical and experimental studies that the spinal cord suffers both primary and secondary damage after acute spinal cord injury. The pathophysiology of secondary injury involves a multitude of cellular and molecular events which progress over the first few days after injury, the most important of which are systemic and local vascular insults, electrolyte shifts, oedema and excitotoxicity. These secondary processes contribute to the evolution of the pathological changes which in the severe injuries progress from central haemorrhagic necrosis involving mainly the grey matter to infarction of both the white and grey matter at the injury site and for a considerable distance proximally and distally. Less severe injuries show a variety of axonal and myelin changes. The concept of secondary injury is consistent with the results of therapeutic approaches to improve outcome.

Entities:  

Mesh:

Year:  1995        PMID: 8974623     DOI: 10.1111/j.1750-3639.1995.tb00619.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  120 in total

1.  Examination of axonal injury and regeneration in micropatterned neuronal culture using pulsed laser microbeam dissection.

Authors:  Amy N Hellman; Behrad Vahidi; Hyung Joon Kim; Wael Mismar; Oswald Steward; Noo Li Jeon; Vasan Venugopalan
Journal:  Lab Chip       Date:  2010-06-09       Impact factor: 6.799

Review 2.  The dark side of neuroplasticity.

Authors:  Arthur Brown; Lynne C Weaver
Journal:  Exp Neurol       Date:  2011-11-12       Impact factor: 5.330

Review 3.  Cellular and paracellular transplants for spinal cord injury: a review of the literature.

Authors:  Martin M Mortazavi; Ketan Verma; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-10-23       Impact factor: 1.475

Review 4.  Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening.

Authors:  Sareh Pandamooz; Mohammad Nabiuni; Jaleel Miyan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

5.  Hemodynamic parameters and timing of surgical decompression in acute cervical spinal cord injury.

Authors:  Sagun Tuli; Jayshree Tuli; William P Coleman; Fred H Geisler; Andrei Krassioukov
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

6.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

Review 7.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 8.  Mesenchymal Stem Cell-Macrophage Choreography Supporting Spinal Cord Repair.

Authors:  Inés Maldonado-Lasunción; Joost Verhaagen; Martin Oudega
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

9.  Temporal and spatial expression of KIF3B after acute spinal cord injury in adult rats.

Authors:  Xiaowei Yu; Hai Wen; Jianhua Cao; Binbin Sun; Tao Ding; Ming Li; Hao Wu; Long Long; Xinghai Cheng; Guangfei Xu; Feng Zhang
Journal:  J Mol Neurosci       Date:  2012-10-24       Impact factor: 3.444

10.  Comparative Examination of Temporal Glyoxalase 1 Variations Following Perforant Pathway Transection, Excitotoxicity, and Controlled Cortical Impact Injury.

Authors:  Philipp Pieroh; Daniel-Christoph Wagner; Beat Alessandri; Mojgan Dabbagh Nazari; Angela Ehrlich; Chalid Ghadban; Constance Hobusch; Gerd Birkenmeier; Faramarz Dehghani
Journal:  Neurotox Res       Date:  2017-09-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.